Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Radiopharm Theranostics, Ltd
University of Pittsburgh
Ohio State University Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Indiana University
H. Lee Moffitt Cancer Center and Research Institute
Shanghai Juncell Therapeutics
University of Virginia
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
Assistance Publique - Hôpitaux de Paris
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
Mayo Clinic
University of Pittsburgh
The University of Hong Kong-Shenzhen Hospital
CivaTech Oncology
Centre Jean Perrin
University of Massachusetts, Worcester
University of Southern California
Miltenyi Biomedicine GmbH
Presage Biosciences
Northwestern University
Xijing Hospital
University of Lausanne Hospitals
University of Virginia
Center for Biomedical Research, Inc.
University of Pennsylvania
Rhode Island Hospital
Columbia University
TuHURA Biosciences, Inc.
Yale University
Presage Biosciences
Shanghai Fengxian District Central Hospital
Northwestern University
Yale University
Center for Biomedical Research, Inc.
Northwestern University
Rhode Island Hospital
Johns Hopkins University
Tulane University
Bispebjerg Hospital
Case Comprehensive Cancer Center
Hospital Italiano de Buenos Aires
University of Miami
Mayo Clinic
Timmune Biotech Inc.
Washington University School of Medicine